Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1950858747;58748;58749 chr2:178593778;178593777;178593776chr2:179458505;179458504;179458503
N2AB1786753824;53825;53826 chr2:178593778;178593777;178593776chr2:179458505;179458504;179458503
N2A1694051043;51044;51045 chr2:178593778;178593777;178593776chr2:179458505;179458504;179458503
N2B1044331552;31553;31554 chr2:178593778;178593777;178593776chr2:179458505;179458504;179458503
Novex-11056831927;31928;31929 chr2:178593778;178593777;178593776chr2:179458505;179458504;179458503
Novex-21063532128;32129;32130 chr2:178593778;178593777;178593776chr2:179458505;179458504;179458503
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGA
  • RefSeq wild type template codon: CCT
  • Domain: Fn3-29
  • Domain position: 30
  • Structural Position: 31
  • Q(SASA): 0.3421
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/E None None 1.0 D 0.852 0.624 0.541466613703 gnomAD-4.0.0 2.40065E-06 None None None None I None 0 0 None 0 0 None 0 0 2.62501E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.9269 likely_pathogenic 0.9468 pathogenic -0.194 Destabilizing 1.0 D 0.729 prob.delet. D 0.52714958 None None I
G/C 0.9787 likely_pathogenic 0.9841 pathogenic -0.809 Destabilizing 1.0 D 0.795 deleterious None None None None I
G/D 0.993 likely_pathogenic 0.9945 pathogenic -0.333 Destabilizing 1.0 D 0.831 deleterious None None None None I
G/E 0.9953 likely_pathogenic 0.9956 pathogenic -0.496 Destabilizing 1.0 D 0.852 deleterious D 0.537998907 None None I
G/F 0.9978 likely_pathogenic 0.9981 pathogenic -0.962 Destabilizing 1.0 D 0.797 deleterious None None None None I
G/H 0.9969 likely_pathogenic 0.9977 pathogenic -0.445 Destabilizing 1.0 D 0.813 deleterious None None None None I
G/I 0.997 likely_pathogenic 0.9972 pathogenic -0.349 Destabilizing 1.0 D 0.804 deleterious None None None None I
G/K 0.9958 likely_pathogenic 0.996 pathogenic -0.599 Destabilizing 1.0 D 0.853 deleterious None None None None I
G/L 0.9969 likely_pathogenic 0.9972 pathogenic -0.349 Destabilizing 1.0 D 0.811 deleterious None None None None I
G/M 0.9983 likely_pathogenic 0.9985 pathogenic -0.371 Destabilizing 1.0 D 0.797 deleterious None None None None I
G/N 0.9943 likely_pathogenic 0.9968 pathogenic -0.254 Destabilizing 1.0 D 0.803 deleterious None None None None I
G/P 0.9994 likely_pathogenic 0.9994 pathogenic -0.265 Destabilizing 1.0 D 0.833 deleterious None None None None I
G/Q 0.9959 likely_pathogenic 0.9965 pathogenic -0.532 Destabilizing 1.0 D 0.834 deleterious None None None None I
G/R 0.9841 likely_pathogenic 0.9837 pathogenic -0.202 Destabilizing 1.0 D 0.836 deleterious N 0.492409101 None None I
G/S 0.9218 likely_pathogenic 0.9436 pathogenic -0.43 Destabilizing 1.0 D 0.8 deleterious None None None None I
G/T 0.9908 likely_pathogenic 0.9923 pathogenic -0.518 Destabilizing 1.0 D 0.851 deleterious None None None None I
G/V 0.9938 likely_pathogenic 0.9944 pathogenic -0.265 Destabilizing 1.0 D 0.816 deleterious D 0.539519844 None None I
G/W 0.994 likely_pathogenic 0.9939 pathogenic -1.109 Destabilizing 1.0 D 0.813 deleterious None None None None I
G/Y 0.9966 likely_pathogenic 0.9973 pathogenic -0.743 Destabilizing 1.0 D 0.792 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.